Table 3 Odds of Tanner stage >1 or TV >3 ml associated with an IQR increase in trimester-specific, SG-corrected in utero urinary phthalate metabolite or BPA concentration^a

0.71 (0.39, 1.28)

1.41 (0.78, 2.54)

0.93 (0.53, 1.61)

1.04 (0.5, 2.14)

0.95 (0.58, 1.55)

0.98 (0.57, 1.68)

0.71 (0.37, 1.36)

0.75 (0.37, 1.51)

1.2 (0.61, 2.36)

1.16 (0.53, 2.54)

0.97 (0.53, 1.77)

1.14 (0.48, 2.73)

1.5 (0.79, 2.85)

1.17 (0.56, 2.48)

1.09 (0.58, 2.03)

1.27 (0.58, 2.81)

0.99 (0.56, 1.74)

0.85 (0.46, 1.57)

0.71 (0.4, 1.29)

0.77 (0.37, 1.62)

0.77 (0.47, 1.27)

0.86 (0.48, 1.52)

0.59 (0.31, 1.13)

0.57 (0.27, 1.21)

0.2 (0.02, 2.76)

1.1 (0.31, 3.9)

0.42 (0.13, 1.36)

0.72 (0.19, 2.73)

0.13 (0.01, 1.56)

0.99 (0.26, 3.73)

0.18 (0.03, 0.97)*

0.31 (0.1, 0.93)*

0.33 (0.02, 4.72)

5.99 (0.5, 72.02)

0.47 (0.16, 1.37)

0.5 (0.11, 2.26)

2.04 (0.36, 11.58)

1.31 (0.22, 7.85)

0.44 (0.15, 1.24)

0.52 (0.17, 1.6)

0 (0, 542.1)

2.22 (0.28, 17.34)

0.27 (0.07, 0.99)*

0.16 (0.03, 1.02)

0.28 (0.02, 3.85)

2.68 (0.48, 15.08)

0.36 (0.13, 1.06)

0.39 (0.11, 1.42)

1.28 (0.67, 2.45)

2.01 (0.94, 4.28)

1.34 (0.68, 2.66)

2.29 (0.87, 5.98)

0.7 (0.39, 1.23)

0.62 (0.3, 1.29)

0.73 (0.33, 1.6)

0.4 (0.16, 1)*

0.56 (0.25, 1.27)

1.59 (0.6, 4.23)

1.03 (0.5, 2.12)

1.07 (0.36, 3.19)

1.33 (0.64, 2.76)

0.75 (0.31, 1.86)

1.32 (0.6, 2.91)

1.16 (0.44, 3.06)

1.21 (0.64, 2.3)

0.99 (0.49, 2)

1.5 (0.75, 3)

1.94 (0.7, 5.34)

1 (0.54, 1.84)

1.66 (0.85, 3.25)

0.88 (0.44, 1.75)

1.35 (0.54, 3.4)